Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 16Recurrence 3Neoplasms, Plasma Cell 2Renal Insufficiency 1Paraproteinemias 1Neoplasms by Histologic Type 1Neoplasms 1Immunoglobulin Light-chain Amyloidosis 1Hypoxia 1High Grade Squamous Intra-epithelial Lesion (HSIL) 1Hematologic Diseases 1Disease Progression 1Blood Protein Disorders 1Amyloidosis 1

Interventions

pomalidomide 1pembrolizumab 1Temozolomide 1Tamsulosin 1Sodium Selenite 1Saline Solution 1Radiomics 1Lidocaine 1Hepatectomy 1Epirubicin 1Dexamethasone 1Cyclophosphamide 1Bevacizumab 110-propargyl-10-deazaaminopterin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Disease Progression × pomalidomide × Clear all
NCT03601624 2018-11-14

MM-POM-2018

Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

Phase 2 Unknown
18 enrolled
Plasma cell

Multiple Myeloma, Recurrence, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡